News
Video
GLP-1 RA antiobesity medications: Patients’ No. 1 question
Author(s):
Key Takeaways
- Patients are curious about GLP-1 RA antiobesity medications, necessitating discussions with healthcare providers.
- Dr. Robert Kushner, an expert in obesity and nutrition, stresses the importance of initiating these conversations.
A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.
Patients have lots of questions regarding the new GLP-1 RA antiobesity medications. But there is a start to every conversation with their physician, nurse practitioner, or primary care provider, said Robert Kushner, MD, who has made a career as a researcher and author about overweight, obesity and nutrition. He’s also a doctor who has treated patients for years through Northwestern University’s Feinberg School of Medicine and Northwestern Medicine’s Center for Lifestyle Medicine.
Newsletter
Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.
